Inequities in lung cancer treatment: lessons from international variation in chemotherapy and radiotherapy use

Lung cancer remains the leading cause of cancer death worldwide. While prevention strategies such as tobacco control remain crucial, differences in survival outcomes between high-income countries suggest that access to effective treatment also plays a key role.1 These differences occur despite similar healthcare expenditure and universal coverage systems, indicating that structural, cultural and clinical factors influence lung cancer care delivery.